Dataset Preview
The full dataset viewer is not available (click to read why). Only showing a preview of the rows.
The dataset generation failed
Error code: DatasetGenerationError
Exception: ArrowInvalid
Message: Failed to parse string: 'Benzinga Newsdesk' as a scalar of type double
Traceback: Traceback (most recent call last):
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1890, in _prepare_split_single
writer.write_table(table)
File "/usr/local/lib/python3.12/site-packages/datasets/arrow_writer.py", line 760, in write_table
pa_table = table_cast(pa_table, self._schema)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2272, in table_cast
return cast_table_to_schema(table, schema)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2224, in cast_table_to_schema
cast_array_to_feature(
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 1795, in wrapper
return pa.chunked_array([func(chunk, *args, **kwargs) for chunk in array.chunks])
^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 2086, in cast_array_to_feature
return array_cast(
^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 1797, in wrapper
return func(array, *args, **kwargs)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/table.py", line 1949, in array_cast
return array.cast(pa_type)
^^^^^^^^^^^^^^^^^^^
File "pyarrow/array.pxi", line 1135, in pyarrow.lib.Array.cast
File "/usr/local/lib/python3.12/site-packages/pyarrow/compute.py", line 412, in cast
return call_function("cast", [arr], options, memory_pool)
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "pyarrow/_compute.pyx", line 604, in pyarrow._compute.call_function
File "pyarrow/_compute.pyx", line 399, in pyarrow._compute.Function.call
File "pyarrow/error.pxi", line 155, in pyarrow.lib.pyarrow_internal_check_status
File "pyarrow/error.pxi", line 92, in pyarrow.lib.check_status
pyarrow.lib.ArrowInvalid: Failed to parse string: 'Benzinga Newsdesk' as a scalar of type double
The above exception was the direct cause of the following exception:
Traceback (most recent call last):
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 1347, in compute_config_parquet_and_info_response
parquet_operations = convert_to_parquet(builder)
^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/src/services/worker/src/worker/job_runners/config/parquet_and_info.py", line 980, in convert_to_parquet
builder.download_and_prepare(
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 884, in download_and_prepare
self._download_and_prepare(
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 947, in _download_and_prepare
self._prepare_split(split_generator, **prepare_split_kwargs)
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1739, in _prepare_split
for job_id, done, content in self._prepare_split_single(
^^^^^^^^^^^^^^^^^^^^^^^^^^^
File "/usr/local/lib/python3.12/site-packages/datasets/builder.py", line 1922, in _prepare_split_single
raise DatasetGenerationError("An error occurred while generating the dataset") from e
datasets.exceptions.DatasetGenerationError: An error occurred while generating the datasetNeed help to make the dataset viewer work? Make sure to review how to configure the dataset viewer, and open a discussion for direct support.
Index float64 | Date string | Article_title string | Stock_symbol string | Publisher null | Lsa_summary string |
|---|---|---|---|---|---|
0 | 2023-12-16 23:00:00+00:00 | Interesting A Put And Call Options For August 2024 | A | null | Because the $125.00 strike represents an approximate 10% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. Of course, a lot of upside could potentially be left on the table if A shares really soar, which is why looking at the trailing twelve month trading history for Agilent Technologies, Inc., as well as studying the business fundamentals becomes important. Below is a chart showing A's trailing twelve month trading history, with the $150.00 strike highlighted in red: Considering the fact that the $150.00 strike represents an approximate 8% premium to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the covered call contract would expire worthless, in which case the investor would keep both their shares of stock and the premium collected. |
1 | 2023-12-12 00:00:00+00:00 | Wolfe Research Initiates Coverage of Agilent Technologies (A) with Outperform Recommendation | A | null | Fintel reports that on December 13, 2023, Wolfe Research initiated coverage of Agilent Technologies (NYSE:A) with a Outperform recommendation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
2 | 2023-12-12 00:00:00+00:00 | Agilent Technologies Reaches Analyst Target Price | A | null | In recent trading, shares of Agilent Technologies, Inc. (Symbol: A) have crossed above the average analyst 12-month target price of $132.36, changing hands for $133.74/share. And so with A crossing above that average target price of $132.36/share, investors in A have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $132.36 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? The Top 25 Broker Analyst Picks of the S&P 500 » Also see: PXMD Insider Buying ETM Insider Buying Funds Holding FXG The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
3 | 2023-12-07 00:00:00+00:00 | Agilent (A) Enhances BioTek Cytation C10 With New Technology | A | null | Per a Grand View Research report, the global microplate reader market is expected to grow at a CAGR of 7.6% during the forecast period 2023-2030. A Mordor Intelligence report indicates the global live cell imaging market size will reach $2.95 billion by 2028, exhibiting a CAGR of 7.06% between 2023 and 2028. Some better-ranked stocks in the broader technology sector are Badger Meter BMI, Arista Networks ANET and Adobe ADBE. |
4 | 2023-12-07 00:00:00+00:00 | Pre-Market Most Active for Dec 7, 2023 : SQQQ, PLTR, TQQQ, ALT, UBER, PFE, GILD, MRK, AMD, NIO, JBLU, AI | A | null | ProShares UltraPro Short QQQ (SQQQ) is -0.15 at $16.37, with 2,061,124 shares traded. Over the last four weeks they have had 6 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2023. Over the last four weeks they have had 4 up revisions for the earnings forecast, for the fiscal quarter ending Mar 2024. |
5 | 2023-12-05 00:00:00+00:00 | A Quantitative Stock Analysis | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
6 | 2023-11-24 00:00:00+00:00 | The Zacks Analyst Blog Highlights Visa, Marriott International, Parker-Hannifin, FedEx and Agilent Technologies | A | null | Stocks recently featured in the blog include: Visa Inc. V, Marriott International, Inc. MAR, Parker-Hannifin Corp. PH, FedEx Corp. FDX and Agilent Technologies, Inc. A. The company is benefiting from higher demand from distributors and end users across the oil and gas, material handling, cars and light trucks, and farm and agriculture markets in the North American region within the Diversified Industrial segment. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. |
7 | 2023-11-22 00:00:00+00:00 | 3 Biotech Stocks With Big-Time Breakthrough Potential | A | null | This approval is crucial for identifying patients with gastric or gastroesophageal junction adenocarcinoma eligible for treatment with KEYTRUDA, an anti-PD-1 therapy developed by Merck (NYSE:MRK). The company presented data on its blood-based early detection program for multiple cancers and results from OncoExTra, which provides information on actionable fusions in people with solid tumors. In a long-term study, DCCR showed a statistically significant improvement over placebo, bringing hope and good vibes to those suffering from this difficult syndrome. |
8 | 2023-11-22 00:00:00+00:00 | Top Research Reports for Visa, Marriott International & Parker-Hannifin | A | null | The company’s stock prices has consistently outperformed the industry, driven by strategic acquisitions and alliances fostering long-term growth. The company is benefiting from higher demand from distributors and end users across the oil and gas, material handling, cars and light trucks, and farm and agriculture markets in the North American region within the Diversified Industrial segment. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Visa (V) Rides On Growing Cross Border Volume, Expenses High Solid Demand & Expansion Effort Aid Marriott (MAR), High Debt Ail Aerospace Systems Unit Aids Parker-Hannifin ( PH ), Costs Hurt Featured Reports FedEx (FDX) Benefits From Dividends & Buyback, Expenses Ail The Zacks analyst likes the shareholder-friendly measures adopted by FedEx. |
9 | 2023-11-21 00:00:00+00:00 | Tuesday Sector Leaders: Healthcare, Consumer Products | A | null | In afternoon trading on Tuesday, Healthcare stocks are the best performing sector, up 0.8%. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Tuesday. Healthcare +0.8% Consumer Products -0.0% Materials -0.0% Industrial -0.1% Utilities -0.2% Financial -0.2% Services -0.3% Energy -0.4% Technology & Communications -0.8% 25 Dividend Giants Widely Held By ETFs » Also see: Funds Holding AB NYCB Historical Stock Prices SAPE Videos The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
10 | 2023-11-21 00:00:00+00:00 | A Quantitative Stock Analysis | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
11 | 2023-11-21 00:00:00+00:00 | Agilent (A) Q4 Earnings & Revenues Beat Estimates, Down Y/Y | A | null | Agilent Technologies A delivered fourth-quarter fiscal 2023 earnings of $1.38 per share, which beat the Zacks Consensus Estimate by 2.99%. Some better-ranked stocks in the broader technology sector are Badger Meter BMI, Arista Networks ANET and Salesforce CRM. Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests. |
12 | 2023-11-21 00:00:00+00:00 | S&P 500 Movers: J, A | A | null | In early trading on Tuesday, shares of Agilent Technologies, topped the list of the day's best performing components of the S&P 500 index, trading up 8.1%. And the worst performing S&P 500 component thus far on the day is Jacobs Solutions, trading down 5.5%. Jacobs Solutions is showing a gain of 7.9% looking at the year to date performance. |
13 | 2023-11-21 00:00:00+00:00 | A Makes Bullish Cross Above Critical Moving Average | A | null | In trading on Tuesday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $124.47, changing hands as high as $124.68 per share. The chart below shows the one year performance of A shares, versus its 200 day moving average: Looking at the chart above, A's low point in its 52 week range is $96.80 per share, with $160.265 as the 52 week high point — that compares with a last trade of $123.46. The A DMA information above was sourced from TechnicalAnalysisChannel.com Click here to find out which 9 other stocks recently crossed above their 200 day moving average » Also see: MOK Historical Stock Prices Top Ten Hedge Funds Holding SWM AIT Dividend Growth Rate The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
14 | 2023-11-20 00:00:00+00:00 | Agilent (A) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates | A | null | While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. |
15 | 2023-11-20 00:00:00+00:00 | Agilent Technologies Q4 Profit Increases, beats estimates | A | null | (RTTNews) - Agilent Technologies (A) reported a profit for its fourth quarter that increased from the same period last year and beat the Street estimates. Excluding items, Agilent Technologies reported adjusted earnings of $404 million or $1.38 per share for the period. Analysts on average had expected the company to earn $1.34 per share, according to figures compiled by Thomson Reuters. |
16 | 2023-11-20 00:00:00+00:00 | After-Hours Earnings Report for November 20, 2023 : A, KEYS, ZM, BRBR, SYM, GBDC, CENTA, CENT, ENTA, XELB | A | null | The electrical test equipment company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.34. The technology services company's consensus earnings per share forecast from the 4 analysts that follow the stock is $-0.06. The financial services company's consensus earnings per share forecast from the 2 analysts that follow the stock is $0.48. |
17 | 2023-11-20 00:00:00+00:00 | Agilent Technologies Q4 23 Earnings Conference Call At 4:30 PM ET | A | null | (RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on November 20, 2023, to discuss Q4 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
18 | 2023-11-16 00:00:00+00:00 | Daily Dividend Report: CSCO,CB,EXR,NOC,A,PHM | A | null | The Board of Directors of Chubb today declared a quarterly dividend equal to $0.86 per share, payable on January 5, 2024 to shareholders of record at the close of business on December 15, 2023. The dividend will be payable out of legal reserves and will be made in United States dollars by the company's transfer agent, as described in the Chubb Limited 2023 proxy statement. The increase will be effective with the Company's next scheduled dividend, which is payable January 3, 2024, to shareholders of record at the close of business on December 19, 2023. |
19 | 2023-11-16 00:00:00+00:00 | What to Note Ahead of Agilent Technologies' (A) Q4 Earnings | A | null | The Zacks Consensus Estimate for earnings is pegged at $1.34 per share, indicating a fall of 12.4% from the year-ago fiscal quarter’s reported figure. Agilent’s strength in the Nucleic Acid Solutions Division business is expected to have continued benefiting the DGG segment’s performance in the fiscal fourth quarter. The Zacks Consensus Estimate for DGG is pegged at $345 million, implying a fall of 2% from the year-ago fiscal quarter’s reported figure. |
20 | 2023-11-16 00:00:00+00:00 | Agilent (A) Boosts DGG Offerings With PD-L1 IHC 22C3 Approval | A | null | Notably, Agilent received FDA approval for its PD-L1 IHC 22C3 pharmDx diagnostic tool, which helps in Gastric or Gastroesophageal Junction Adenocarcinoma diagnosis. Additionally, PD-L1 IHC 22C3 pharmDx aids in identifying patients with non-small cell lung, esophageal, cervical, head and neck and triple-negative breast cancer who may be eligible for KEYTRUDA treatment. Further, the agreement involves the provision of an Agilent Magnis NGS Preparation System for investigating specific details in Asian cancer cohorts, where tissue samples are limited locally and regionally. |
21 | 2023-11-14 00:00:00+00:00 | Agilent Technologies Announces FDA Approval For PD-L1 IHC 22C3 PharmDx - Quick Facts | A | null | (RTTNews) - Agilent Technologies Inc. (A) has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric or Gastroesophageal Junction Adenocarcinoma who may be eligible for treatment with KEYTRUDA, Merck's anti-PD-1 therapy. The company noted that this marks the sixth cancer type for which PD-L1 IHC 22C3 pharmDx has gained FDA approval. PD-L1 IHC 22C3 pharmDx was developed by Agilent in partnership with Merck as a companion diagnostic for KEYTRUDA. |
22 | 2023-11-13 00:00:00+00:00 | Analysts Estimate Agilent Technologies (A) to Report a Decline in Earnings: What to Look Out for | A | null | While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. While management's discussion of business conditions on theearnings callwill mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP. |
23 | 2023-11-08 00:00:00+00:00 | Agilent Technologies (A) Stock Dips While Market Gains: Key Facts | A | null | Alongside, our most recent consensus estimate is anticipating revenue of $1.67 billion, indicating a 9.65% downward movement from the same quarter last year. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. |
24 | 2023-11-07 00:00:00+00:00 | A Quantitative Stock Analysis | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
25 | 2023-11-01 00:00:00+00:00 | Agilent Technologies (A) Stock Dips While Market Gains: Key Facts | A | null | Analysts and investors alike will be keeping a close eye on the performance of Agilent Technologies in its upcoming earnings disclosure. At the same time, our most recent consensus estimate is projecting a revenue of $1.67 billion, reflecting a 9.65% fall from the equivalent quarter last year. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. |
26 | 2023-10-31 00:00:00+00:00 | Ametek (AME) Q3 Earnings Surpass Estimates | A | null | Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. This scientific instrument maker is expected to post quarterly earnings of $1.34 per share in its upcoming report, which represents a year-over-year change of -12.4%. |
27 | 2023-10-30 00:00:00+00:00 | Oversold Conditions For Agilent Technologies (A) | A | null | In trading on Monday, shares of Agilent Technologies, Inc. (Symbol: A) entered into oversold territory, hitting an RSI reading of 25.5, after changing hands as low as $96.80 per share. A bullish investor could look at A's 25.5 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of A shares: Looking at the chart above, A's low point in its 52 week range is $96.80 per share, with $160.265 as the 52 week high point — that compares with a last trade of $98.86. |
28 | 2023-10-24 00:00:00+00:00 | A Quantitative Stock Analysis | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
29 | 2023-10-24 00:00:00+00:00 | Danaher beats profit estimates on respiratory testing demand | A | null | Oct 24 (Reuters) - Danaher DHR.N on Tuesday beat Wall Street estimates for third-quarter profit as strong demand for its diagnostic tests for respiratory diseases helped soften the blow from weaker sales at the healthcare conglomerate's life-sciences unit. Life sciences companies such as Danaher, Agilent A.N and Thermo Fisher TMO.N cut their annual profit forecasts earlier this year as some clients slashed their budgets for biopharma services due to a funding crunch. Rising interest rates squeezed funding needed for drug development programs, weighing on demand for contract research services offered by Danaher and rival Thermo Fisher. |
30 | 2023-10-19 00:00:00+00:00 | December 15th Options Now Available For Agilent Technologies (A) | A | null | Because the $105.00 strike represents an approximate 4% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if A shares really soar, which is why looking at the trailing twelve month trading history for Agilent Technologies, Inc., as well as studying the business fundamentals becomes important. |
31 | 2023-10-17 00:00:00+00:00 | Carl Icahn sues Illumina board for violating 'fiduciary duties' | A | null | Changes source in headline, recasts paragraph 1, adds background in paragraphs 4-6 Oct 17 (Reuters) - Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina ILMN.O and accused them of breaching their fiduciary duties, according to a sealed copy of the complaint on Tuesday. The publicly available version of the complaint did not contain further details, but Icahn told the 13D investor conference in New York on Tuesday that the lawsuit pertained to Illumina completing its acquisition of cancer detection test maker Grail. Last week, Illumina said it would divest cancer test maker Grail in 12 months according to the terms of the European Commission's order, if the life sciences company does not win its challenge in court. |
32 | 2023-10-10 00:00:00+00:00 | Agilent (A) Bolsters NTD Research With SIDC Partnership | A | null | Per an MMR research report, the global NTD diagnosis market size is expected to reach $8.97 billion by 2029, exhibiting a CAGR of 4.5% between 2022 and 2029. A Grand View Research report predicts the global NTD diagnosis market size to witness a CAGR of 4.5% during the forecast period of 2023-2030. The solution includes a dedicated column thermostat, multi-angle light scattering detector, GPC/SEC-Ready Kit, and WinGPC Software for advanced material characterization. |
33 | 2023-10-05 00:00:00+00:00 | Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar | A | null | The Federal Reserve’s aggressive posture against inflation combined with soaring interest rates have investors taking defensive measures. In effect, Charles River is a tax on the entire biotech industry, with their consistent postings of compounded earnings per share growth rate in the teens since the turn of the century. Keysight sprung up originally as Hewlett-Packard‘s Test & Measurement division more than half a century ago, and was ultimately spun off from Agilent (NYSE:A) into its own publicly-traded entity in 2014. |
34 | 2023-09-29 00:00:00+00:00 | Barclays Maintains Agilent Technologies (A) Underweight Recommendation | A | null | Fintel reports that on September 29, 2023, Barclays maintained coverage of Agilent Technologies (NYSE:A) with a Underweight recommendation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
35 | 2023-09-28 00:00:00+00:00 | Ex-Dividend Reminder: Upbound Group, Cardinal Health and Agilent Technologies | A | null | Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. If they do continue, the current estimated yields on annualized basis would be 4.58% for Upbound Group Inc, 2.27% for Cardinal Health, Inc., and 0.81% for Agilent Technologies, Inc.. Free Report: Top 8%+ Dividends (paid monthly) In Thursday trading, Upbound Group Inc shares are currently up about 0.9%, Cardinal Health, Inc. shares are up about 0.3%, and Agilent Technologies, Inc. shares are up about 0.3% on the day. dividend stocks should be on your radar screen » Also see: Institutional Holders of AX IBTD YTD Return CRG Split History The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
36 | 2023-09-25 00:00:00+00:00 | After Hours Most Active for Sep 25, 2023 : OKE, APO^A, ET, XPEV, BAC, FINV, MCHI, ARM, CSCO, CMCSA, QQQ, AAPL | A | null | As reported by Zacks, the current mean recommendation for FINV is in the "strong buy range". iShares MSCI China ETF (MCHI) is -0.0345 at $43.38, with 1,662,357 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Sep 2024. |
37 | 2023-09-21 00:00:00+00:00 | Daily Dividend Report: CLX,CVX,A,SBUX,AMT | A | null | CVS Health has announced that its board of directors has approved a quarterly dividend of sixty and a half cents per share on the Common Stock. Agilent Technologies, today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on Oct. 25, 2023, to all shareholders of record as of the close of business on Oct. 3, 2023. Starbucks today announced that its Board of Directors approved an increase in the company's quarterly cash dividend from $0.53 to $0.57 per share of outstanding Common Stock. |
38 | 2023-09-21 00:00:00+00:00 | Agilent Technologies is Now Oversold (A) | A | null | A bullish investor could look at A's 26.2 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of A shares: Looking at the chart above, A's low point in its 52 week range is $109 per share, with $160.265 as the 52 week high point — that compares with a last trade of $110.56. Find out what 9 other oversold stocks you need to know about » Also see: Stocks Being Sold By Hedge Funds LII Average Annual Return ESP Past Earnings The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
39 | 2023-09-20 00:00:00+00:00 | Agilent (A) Boosts Genomic Profiling With New Collaboration | A | null | The research focuses on improving tumor genome characterization and utilizing this data in patient care to enhance clinical trials, oncology diagnostics and treatment decisions. Notably, this collaboration involves the provision of the Agilent Magnis NGS Preparation System, which is used to study details specific to Asian cancer cohorts where tissue samples are limited. The company also partnered with Theragen Bio to improve precision oncology in South Korea through advanced bioinformatic solutions, leveraging their combined expertise in cancer genomic profiling design and software knowledge. |
40 | 2023-09-15 00:00:00+00:00 | Notable Friday Option Activity: PRGS, POOL, A | A | null | Particularly high volume was seen for the $50 strike put option expiring October 20, 2023, with 502 contracts trading so far today, representing approximately 50,200 underlying shares of PRGS. Especially high volume was seen for the $360 strike put option expiring September 15, 2023, with 501 contracts trading so far today, representing approximately 50,100 underlying shares of POOL. Particularly high volume was seen for the $130 strike call option expiring October 20, 2023, with 1,666 contracts trading so far today, representing approximately 166,600 underlying shares of A. |
41 | 2023-09-15 00:00:00+00:00 | Friday Sector Leaders: Utilities, Healthcare | A | null | Combined, DTE and CNP make up approximately 4.3% of the underlying holdings of XLU. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Friday. Utilities -0.0% Healthcare -0.3% Consumer Products -0.4% Financial -0.5% Industrial -0.6% Materials -0.9% Services -1.0% Energy -1.4% Technology & Communications -1.5% 25 Dividend Giants Widely Held By ETFs » Also see: OUT Historical Stock Prices AKRX market cap history DQ Split History The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
42 | 2023-09-14 00:00:00+00:00 | Agilent (A) Down 6.5% Since Last Earnings Report: Can It Rebound? | A | null | Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. The decline was attributed to sluggishness in Chemistry & Advanced Materials and Pharma & Biopharma markets due to weak momentum in China. LSAG: The segment accounted for $927 million or 55% of its total revenues, down 9% on a reported as well as on a core basis from the respective prior-year fiscal quarter’s levels. |
43 | 2023-09-12 00:00:00+00:00 | Agilent To Sell Resolution Bioscience To Exact Sciences For Undisclosed Sum | A | null | Resolution Bioscience is a developer of next-generation sequencing-based precision oncology solutions. Sam Raha, Senior Vice President at Agilent, said: "Exact is a leading centralized laboratory for advanced cancer diagnostic testing with significant capabilities and resources in this area, which makes Resolution Bioscience a strategic fit for them. This agreement will enable the talented Resolution Bioscience team to continue their work advancing diagnostic solutions for their customers and patients, a very positive outcome of this transaction." |
44 | 2023-09-05 00:00:00+00:00 | Illumina names Agilent exec Jacob Thaysen as CEO | A | null | Adds background in paragraphs 2-3 Sept 5 (Reuters) - Illumina Inc ILMN.O said on Tuesday its board has named Agilent Technologies' A.N executive Jacob Thaysen as the U.S. genetic testing company's CEO. Thaysen would replace Charles Dadswell, who has been serving as Illumina's interim CEO since June. The appointment comes months after Illumina's former CEO Francis deSouza stepped down, marking a victory for activist investor Carl Icahn. |
45 | 2023-09-01 00:00:00+00:00 | Do Options Traders Know Something About Agilent (A) Stock We Don't? | A | null | Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. |
46 | 2023-08-31 00:00:00+00:00 | Building Wealth with Spinoffs: How Adding These Gems Can Transform Your Portfolio | A | null | To fully comprehend the Spinoff and its ramifications, investors should also look for information from reliable financial analysts, subject-matter experts, and formal regulatory filings, such as those with the Securities and Exchange Commission (SEC). The management teams of these newly independent entities tend to be more agile and dedicated to the success of their specific business, potentially translating into better growth prospects. This outperformance can be attributed to a combination of factors, including improved focus, better capital allocation decisions, and the market's eventual recognition of the Spinoff's value proposition. |
47 | 2023-08-25 00:00:00+00:00 | EXCLUSIVE-Danaher in the lead to acquire biomedical equipment vendor Abcam -sources | A | null | By David Carnevali NEW YORK, Aug 25 (Reuters) - Danaher Corp DHR.N is in the lead to acquire Abcam Plc ABCM.O, a provider of supplies to life science researchers with a market value of $5.4 billion, as it expands its biomedical offerings, people familiar with the matter said on Friday. One of the sources said the deal price would be close to Abcam's current valuation, given that its stock has already risen more than 20% after Bloomberg News reported on June 16 that the company was fielding takeover interest. Danaher, one of the world's largest suppliers of diagnostic tools with a market value of $190 billion, has turned to dealmaking to expand in the sector. |
48 | 2023-08-25 00:00:00+00:00 | EXCLUSIVE-Danaher in the lead to acquire biomedical equipment vendor Abcam-sources | A | null | By David Carnevali NEW YORK, Aug 25 (Reuters) - Danaher Corp DHR.N is in the lead to acquire Abcam Plc ABCM.O, a provider of supplies to life science researchers with a market value of $5.1 billion, as it expands its biomedical offerings, people familiar with the matter said on Friday. Abcam believes that Danaher's all-cash offer is superior to a rival bid from Agilent Technologies Inc A.N, the sources said. If the negotiations conclude successfully, a deal could be announced as early as next week, the sources said, cautioning that no agreement is certain and that the outcome could still change. |
49 | 2023-08-21 00:00:00+00:00 | Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble | A | null | Investors have rightly or wrongly decided that the contraction of its margins in light of double-digit revenue growth suggests the quality of the sales increase for the maker of sleep apnea equipment is suspect. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble appeared first on InvestorPlace. |
50 | 2023-08-18 00:00:00+00:00 | These 3 Unusually Active Options Have 1 Thing in Common | A | null | Investors are worried about many subjects, including further interest rate hikes, higher bond yields, and a faltering Chinese economy. Almost every company with a presence in EVs is losing money and ratcheting their production outputs lower to recognize that the uptake by consumers, especially in North America, will be slower than anticipated. More Options News from Barchart Walmart's Better Than Expected Earnings and FCF Could Push WMT Stock Higher Here’s the Real Lowdown of Ross Stores’ (ROST) Q2 Report Somebody Really Must Like Suncor Given Its Unusual Options Activity Attention Speculators: Going Long Discover Financial Services (DFS) Might Not Be a Bad Idea On the date of publication, Will Ashworth did not have (either directly or indirectly) positions in any of the securities mentioned in this article. |
51 | 2023-08-17 00:00:00+00:00 | Stocks Move Higher Before the Open as Investors Weigh Fed Minutes, Walmart Earnings on Tap | A | null | The Euro Stoxx 50 futures are down -0.40% this morning as the minutes of the U.S. Federal Reserve’s July meeting sparked concerns the central bank will continue to raise interest rates to contain inflation while downbeat earnings also hurt risk appetite. Reuters reported on Thursday that Zhongzhi Enterprise Group informed its investors about a liquidity crisis and its intention to conduct debt restructuring as the Chinese asset manager contends with a worsening property market downturn. You can see more pre-market stock movers here Today’s U.S. Earnings Spotlight: Thursday - August 17th Walmart (WMT), Applied Materials (AMAT), Ross Stores (ROST), Bill Com (BILL), Tapestry (TPR), Globant SA (GLOB), Bilibili (BILI), Lumentum Holdings Inc (LITE), Arcos Dorados (ARCO), Corporacion America Airports (CAAP), Farfetch A (FTCH), SFLoration Ltd (SFL), SGHC Limited (SGHC), Dole (DOLE), Ehang (EH), SpartanNash Co (SPTN), Despegar.com (DESP), Nano X (NNOX), Gambling.com Group (GAMB), LSI Industries (LYTS). |
52 | 2023-08-16 00:00:00+00:00 | TD Cowen Maintains Agilent Technologies (A) Outperform Recommendation | A | null | Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. Second Amended and Restated Certificate of Incorporation Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
53 | 2023-08-16 00:00:00+00:00 | Stocks Mixed as Markets Await Minutes of the July FOMC Meeting | A | null | MarketAxcess Holdings (MKTX) is up more than +3% on signs of insider buying after an SEC filing showed CEO Concannon purchased $1.02 million of shares on Monday. In addition, the deepening liquidity crisis in China has boosted safe-haven demand for precious metals after Zhongrong International Trust missed payments on dozens of its investment products. What you need to know… The S&P 500 Index ($SPX) (SPY) today is down -0.17%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.03%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.46%. |
54 | 2023-08-16 00:00:00+00:00 | Jefferies Maintains Agilent Technologies (A) Buy Recommendation | A | null | A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
55 | 2023-08-16 00:00:00+00:00 | Stocks Fall and Bond Yields Climb as Fed Remains Hawkish | A | null | Stock indexes came under pressure Wednesday afternoon when bond yields jumped after the minutes of the July 25-26 FOMC meeting stated that policymakers saw “significant” inflation risks that may merit more rate hikes. More Stock Market News from Barchart Dollar Advances after the Hawkish July FOMC Meeting Minutes Crude Prices Retreat on Chinese Growth Concerns Forecasts for Cooler U.S. Weather Undercut Nat-Gas Prices 2 Energy Stocks Wall Street Predicts Will Rally 25% or More On the date of publication, Rich Asplund did not have (either directly or indirectly) positions in any of the securities mentioned in this article. |
56 | 2023-08-16 00:00:00+00:00 | Wednesday Sector Laggards: Healthcare, Consumer Products | A | null | Combined, RMD and A make up approximately 1.2% of the underlying holdings of XLV. Comparing these stocks and ETFs on a trailing twelve month basis, below is a relative stock price performance chart, with each of the symbols shown in a different color as labeled in the legend at the bottom: Here's a snapshot of how the S&P 500 components within the various sectors are faring in afternoon trading on Wednesday. Utilities +0.7% Financial -0.0% Consumer Products -0.3% Services -0.3% Technology & Communications -0.3% Industrial -0.3% Materials -0.3% Energy -0.3% Healthcare -0.6% 10 ETFs With Stocks That Insiders Are Buying » Also see: STRT market cap history Top Ten Hedge Funds Holding SGNT CE YTD Return The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
57 | 2023-08-16 00:00:00+00:00 | Credit Suisse Maintains Agilent Technologies (A) Outperform Recommendation | A | null | Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. Second Amended and Restated Certificate of Incorporation Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
58 | 2023-08-16 00:00:00+00:00 | Evercore ISI Group Maintains Agilent Technologies (A) In-Line Recommendation | A | null | Fintel reports that on August 16, 2023, Evercore ISI Group maintained coverage of Agilent Technologies (NYSE:A) with a In-Line recommendation. Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
59 | 2023-08-16 00:00:00+00:00 | Barclays Maintains Agilent Technologies (A) Underweight Recommendation | A | null | Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. Second Amended and Restated Certificate of Incorporation Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
60 | 2023-08-16 00:00:00+00:00 | Baird Maintains Agilent Technologies (A) Outperform Recommendation | A | null | Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. Second Amended and Restated Certificate of Incorporation Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
61 | 2023-08-16 00:00:00+00:00 | Stocks Slightly Higher as Markets Await Minutes of the July FOMC Meeting | A | null | MarketAxcess Holdings (MKTX) is up more than +3% on signs of insider buying after an SEC filing showed CEO Concannon purchased $1.02 million of shares on Monday. In addition, the deepening liquidity crisis in China has boosted safe-haven demand for precious metals after Zhongrong International Trust missed payments on dozens of its investment products. Gains in silver were limited after JPMorgan Chase and Barclays cut their China 2023 GDP estimates, a bearish factor for industrial metals demand. |
62 | 2023-08-16 00:00:00+00:00 | JP Morgan Maintains Agilent Technologies (A) Overweight Recommendation | A | null | Additional reading: Agilent Reports Third-Quarter Fiscal Year 2023 Financial Results Delivers on Q3; adjusts full-year outlook to reflect softer market conditions CREDIT AGREEMENT dated as of June 7, 2023 AGILENT TECHNOLOGIES, INC., The LENDERS Party Hereto, BNP PARIBAS, as Administrative Agent, CITIBANK, N.A., BANK OF AMERICA, N.A. WELLS FARGO BANK, NATIONAL ASSOCIATION, as Syndicati Agilent Reports Second-Quarter Fiscal Year 2023 Financial Results Delivers solid results; adjusts full-year guidance in an increasingly challenging market Amended and Restated Bylaws of Agilent Technologies, Inc., incorporated by reference to Exhibit 3. Second Amended and Restated Certificate of Incorporation Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. |
63 | 2023-08-15 00:00:00+00:00 | Agilent Technologies Q3 23 Earnings Conference Call At 4:30 PM ET | A | null | (RTTNews) - Agilent Technologies (A) will host a conference call at 4:30 PM ET on August 15, 2023, to discuss Q3 23 earnings results. To access the live webcast, log on to https://www.investor.agilent.com/news-and-events/events/default.aspx The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
64 | 2023-08-15 00:00:00+00:00 | Markets Remain Sold; H&R Block (HRB), Agilent (A) Beat | A | null | Tomorrow we get another fairly eventful day, with Housing Starts and Building Permits, as well as Industrial Production and Capacity Utilization, all for the month of July coming out before the opening bell. In the morning, we’ll see Q2 results from Target TGT and after the close Cisco Systems CSCO, both of which are expected to put up big earnings gains from the year-ago quarter. It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. |
65 | 2023-08-15 00:00:00+00:00 | Agilent (A) Reports Q3 Earnings: What Key Metrics Have to Say | A | null | While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year. |
66 | 2023-08-15 00:00:00+00:00 | Agilent Technologies cuts annual forecasts on China weakness | A | null | By Pratik Jain Aug 15 (Reuters) - Medical equipment maker Agilent Technologies A.N cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery. The sales miss was due to softness in genomics and the shutdown of its Resolution Bioscience business, which offered next-generation sequencing-based cancer diagnostics solutions. Agilent CEO Mike McMullen flagged performance of its largest unit that provides laboratory instruments, consumables and software continues to be affected by the market environment in China. |
67 | 2023-08-15 00:00:00+00:00 | After-Hours Earnings Report for August 15, 2023 : ALC, A, NU, JKHY, HRB, DLO, MRCY, LRN, DADA, KTCC, GBNH | A | null | The medical instruments company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.62. The electrical test equipment company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.37. The electrical instrument company's consensus earnings per share forecast from the 1 analyst that follows the stock is $0.15. |
68 | 2023-08-15 00:00:00+00:00 | Stock Index Futures Plunge on Pressure from Rising Bond Yields, China Data Disappoints | A | null | China’s Shanghai Composite today closed lower even after the central bank unexpectedly cut a key interest rate to bolster growth, following the latest data indicating a further slowdown in the country’s economic activity. At the same time, Japan’s Nikkei 225 Stock Index closed higher today, tracking Wall Street’s firm overnight finish, and market sentiment was additionally lifted by stronger-than-expected economic growth data. Arena Group Holdings Inc (AREN) soared about +18% in pre-market trading after the company signed a binding letter of intent with Simplify Inventions, LLC and its founder, Manoj Bhargava, to acquire certain assets of its subsidiary Bridge Media Networks. |
69 | 2023-08-15 00:00:00+00:00 | Agilent Technologies Q3 Profit Decreases, but beats estimates | A | null | (RTTNews) - Agilent Technologies (A) revealed a profit for third quarter that decreased from last year but beat the Street estimates. Excluding items, Agilent Technologies reported adjusted earnings of $422 million or $1.43 per share for the period. Analysts on average had expected the company to earn $1.36 per share, according to figures compiled by Thomson Reuters. |
70 | 2023-08-14 00:00:00+00:00 | Validea Detailed Fundamental Analysis - A | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
71 | 2023-08-14 00:00:00+00:00 | Stocks Set to Open Lower as Investors Await FOMC Minutes, Retail Earnings | A | null | On the ground of this, China’s banking regulator announced it would set up a task force dedicated to assessing risks associated with Zhongzhi Enterprise Group Co. Investor attention is now squarely on Chinese retail sales and industrial production data due on Tuesday. Nikola Corp (NKLA) plunged over -15% in pre-market trading after the company announced a recall of all battery-powered electric trucks it had previously delivered due to two battery fires, and it also temporarily suspended sales of new battery-electric vehicles. You can see more pre-market stock movers here Today’s U.S. Earnings Spotlight: Monday - August 14th Roivant Sciences (ROIV), Monday.Com (MNDY), Natura & Co (NTCO), Beach Energy (BCHEY), Rumble (RUM), Getty Images Holdings (GETY), JinkoSolar (JKS), Definitive Healthcare (DH), Navitas Semiconductor (NVTS), Altus Power (AMPS), Ast Spacemobile (ASTS), Ferroglobe (GSM), Yalla (YALA), Hut 8 Mining (HUT), Terawulf (WULF), CompoSecure (CMPO). |
72 | 2023-08-14 00:00:00+00:00 | Stocks Set to Open Higher as Investors Await FOMC Minutes, Retail Earnings | A | null | On the ground of this, China’s banking regulator announced it would set up a task force dedicated to assessing risks associated with Zhongzhi Enterprise Group Co. Investor attention is now squarely on Chinese retail sales and industrial production data due on Tuesday. Nikola Corp (NKLA) plunged over -15% in pre-market trading after the company announced a recall of all battery-powered electric trucks it had previously delivered due to two battery fires, and it also temporarily suspended sales of new battery-electric vehicles. You can see more pre-market stock movers here Today’s U.S. Earnings Spotlight: Monday - August 14th Roivant Sciences (ROIV), Monday.Com (MNDY), Natura & Co (NTCO), Beach Energy (BCHEY), Rumble (RUM), Getty Images Holdings (GETY), JinkoSolar (JKS), Definitive Healthcare (DH), Navitas Semiconductor (NVTS), Altus Power (AMPS), Ast Spacemobile (ASTS), Ferroglobe (GSM), Yalla (YALA), Hut 8 Mining (HUT), Terawulf (WULF), CompoSecure (CMPO). |
73 | 2023-08-11 00:00:00+00:00 | Agilent Technologies (A) to Post Q3 Earnings: What's in Store? | A | null | The Zacks Consensus Estimate for earnings is pegged at $1.37 per share, indicating growth of 2.2% from the year-ago fiscal quarter’s reported figure. The Zacks Consensus Estimate for ACG is pegged at $377 million, implying growth of 5% from the year-ago fiscal quarter’s reported figure. Further, Agilent’s strength in NASD (Nucleic Acid Solutions Division) business is expected to have continued benefiting the DGG segment’s performance in the fiscal third quarter. |
74 | 2023-08-09 00:00:00+00:00 | Agilent Technologies (A) Stock Moves -0.56%: What You Should Know | A | null | Electronics - Testing Equipment stocks are, on average, holding a PEG ratio of 2.87 based on yesterday's closing prices. Zacks Reveals ChatGPT "Sleeper" Stock One little-known company is at the heart of an especially brilliant Artificial Intelligence sector. As a service to readers, Zacks is providing a bonus report that names and explains this explosive growth stock and 4 other "must buys." |
75 | 2023-08-07 00:00:00+00:00 | Interesting A Put And Call Options For June 2024 | A | null | Because the $125.00 strike represents an approximate 2% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 99%. Of course, a lot of upside could potentially be left on the table if A shares really soar, which is why looking at the trailing twelve month trading history for Agilent Technologies, Inc., as well as studying the business fundamentals becomes important. |
76 | 2023-08-03 00:00:00+00:00 | Cognex Corporation (CGNX) Beats Q2 Earnings and Revenue Estimates | A | null | While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. This scientific instrument maker is expected to post quarterly earnings of $1.37 per share in its upcoming report, which represents a year-over-year change of +2.2%. With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. |
77 | 2023-07-31 00:00:00+00:00 | Stocks See Support from Global Economic Optimism | A | null | On Sunday, Minneapolis Fed President Kashkari said the inflation outlook in the U.S. is "quite positive" and that "the base case scenario seems to be that we'll have a slowing economy, but that we would avoid a recession." Also, Chicago Fed President Goolsbee said today that monthly inflation readings are coming in "quite good," but he hasn't yet decided on whether to support pausing interest-rate increases at the next FOMC meeting. The yen today dropped to a 3-week high low against the dollar after the BOJ announced an unscheduled bond-purchase operation in an attempt to keep 10-year JGB bond yields from climbing. |
78 | 2023-07-31 00:00:00+00:00 | Validea Detailed Fundamental Analysis - A | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
79 | 2023-07-26 00:00:00+00:00 | Agilent Technologies (A) Gains As Market Dips: What You Should Know | A | null | To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. Electronics - Testing Equipment stocks are, on average, holding a PEG ratio of 2.86 based on yesterday's closing prices. Today you can invest in the wave of the future, an automation that answers follow-up questions … admits mistakes … challenges incorrect premises … rejects inappropriate requests. |
80 | 2023-07-20 00:00:00+00:00 | Healthcare Prime Destination for Bargains, Quality | A | null | With the hoopla surrounding mega-cap growth stocks this year, some slower-moving sectors may not be getting the attention they deserve. Part of the issue confounding healthcare stocks this year is that the cap-weighted version of the S&P 500 Health Care Index is pointing lower. As things stand today, RSPH is sharply outperforming its cap-weighted rivals year-to-date while sporting less annualized volatility than the S&P 500. |
81 | 2023-07-17 00:00:00+00:00 | Validea Detailed Fundamental Analysis - A | A | null | Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. |
82 | 2023-07-06 00:00:00+00:00 | Agilent Technologies (A) Dips More Than Broader Markets: What You Should Know | A | null | In the latest trading session, Agilent Technologies (A) closed at $118.43, marking a -0.9% move from the previous day. For comparison, its industry has an average Forward P/E of 25.92, which means Agilent Technologies is trading at a discount to the group. The Electronics - Testing Equipment industry currently had an average PEG ratio of 2.84 as of yesterday's close. |
83 | 2023-07-03 00:00:00+00:00 | Validea's Top 5 Health Care Stocks Based On Joel Greenblatt - 7/3/2023 | A | null | A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest. The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria. |
84 | 2023-06-28 00:00:00+00:00 | Ex-Dividend Reminder: Agilent Technologies, Cardinal Health and Encompass Health | A | null | As a percentage of A's recent stock price of $116.20, this dividend works out to approximately 0.19%, so look for shares of Agilent Technologies, Inc. to trade 0.19% lower — all else being equal — when A shares open for trading on 6/30/23. Therefore, a good first due diligence step in forming an expectation of annual yield going forward, is looking at the history above, for a sense of stability over time. dividend stocks should be on your radar screen » Also see: Institutional Holders of UVCL UGI Historical Stock Prices FTI Options Chain The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
85 | 2023-06-23 00:00:00+00:00 | Agilent Technologies (A) Gains As Market Dips: What You Should Know | A | null | Agilent Technologies (A) closed at $119.42 in the latest trading session, marking a +0.62% move from the prior day. It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. |
86 | 2023-06-22 00:00:00+00:00 | Agilent (A) Down 2.2% Since Last Earnings Report: Can It Rebound? | A | null | Will the recent negative trend continue leading up to its next earnings release, or is Agilent due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Top-line growth was driven by strong momentum across Food, Academia & Gov’t and Chemistry & Advanced Materials markets. |
87 | 2023-06-21 00:00:00+00:00 | Agilent Technologies Stock: Ready to Rise off the Floor | A | null | This division provides instruments and services to enable researchers and scientists to perform life science applications like DNA sequencing, metabolomics and protein analysis. This division provides equipment, instruments, software and services to laboratories in various industries, including healthcare, pharmaceuticals, food and beverage, environmental and forensics. He explained that a recovery needed in margins and a lack of revenue catalysts in the back half the analyst downgraded Agilent to "sector weight." |
88 | 2023-06-21 00:00:00+00:00 | Validea's Top 5 Health Care Stocks Based On Martin Zweig - 6/21/2023 | A | null | A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest. The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria. |
89 | 2023-06-20 00:00:00+00:00 | Medical Stocks Waters, Agilent, Illumina Show Growth Potential | A | null | GARP focuses on factors such as earnings growth rates, price-to-earnings ratios, and other valuation metrics to assess the investment potential of a company. Agilent Technologies analyst ratings show a consensus view of “moderate buy” on the stock, with a price target of $151.35 and an upside of 24.95%. The Federal Trade Commission issued an order requiring Illumina to divest Grail, which makes a multi-cancer early detection test. |
90 | 2023-06-14 00:00:00+00:00 | Agilent (A) Boosts LSAG Segment With New GPC/SEC Solutions | A | null | Agilent Technologies A is constantly gaining traction in molecular analyses on the back of its strength in liquid chromatography mass spectrometry (LCMS) offerings. This is evident from its latest InfinityLab Gel Permeation Chromatography/Size Exclusion Chromatography (GPC/SEC) solutions, which the company is gearing up to showcase at the HPLC 2023 conference. Notably, the new additions include the likes GPC/SEC column thermostat, the GPC/SEC-Ready Kit, a multi-angle light scattering detector and the powerful WinGPC Software. |
91 | 2023-06-07 00:00:00+00:00 | Agilent (A) Boosts LCMS Portfolio With New Systems Launch | A | null | We believe the company’s strong focus on bolstering the LSAG segment is expected to contribute well to its overall performance, which in turn is likely to aid it in winning investors’ confidence in the days ahead. Also, Agilent announced the acquisition of Avida Biomed, which develops high-performance target enrichment workflows to aid clinical researchers using next-generation sequencing (NGS) approaches in studying cancer. Discover 5 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale. |
92 | 2023-06-02 00:00:00+00:00 | After Hours Most Active for Jun 2, 2023 : UPWK, QQQ, LCID, INTC, GOOGL, AAPL, BAC, T, NEE, VZ, PFE, AI | A | null | As reported in the last short interest update the days to cover for LCID is 9.268482; this calculation is based on the average trading volume of the stock. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Jun 2023. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2023. |
93 | 2023-05-29 00:00:00+00:00 | Validea's Top 5 Health Care Stocks Based On Martin Zweig - 5/29/2023 | A | null | A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest. The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria. |
94 | 2023-05-24 00:00:00+00:00 | Stifel Maintains Agilent Technologies (A) Hold Recommendation | A | null | A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Key filings for this company: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K This story originally appeared on Fintel. |
95 | 2023-05-24 00:00:00+00:00 | B of A Securities Maintains Agilent Technologies (A) Buy Recommendation | A | null | A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Key filings for this company: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K This story originally appeared on Fintel. |
96 | 2023-05-24 00:00:00+00:00 | Wells Fargo Maintains Agilent Technologies (A) Overweight Recommendation | A | null | A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Key filings for this company: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K This story originally appeared on Fintel. |
97 | 2023-05-24 00:00:00+00:00 | Baird Maintains Agilent Technologies (A) Outperform Recommendation | A | null | A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Key filings for this company: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K This story originally appeared on Fintel. |
98 | 2023-05-24 00:00:00+00:00 | Why Agilent Technologies Stock Is Sinking Today | A | null | It posted net income of $302 million, or $1.02 per share, based on generally accepted accounting principles (GAAP). Although Agilent narrowly topped the consensus Wall Street earnings estimate for the latest quarter, the company's guidance fell short. McMullen noted in Agilent's quarterly conference call that "continued macroeconomic uncertainty coupled with stresses in the banking system have accelerated a more conservative approach from our customers." |
99 | 2023-05-24 00:00:00+00:00 | Credit Suisse Maintains Agilent Technologies (A) Outperform Recommendation | A | null | A payout ratio greater than one means the company is dipping into savings in order to maintain its dividend - not a healthy situation. Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. Key filings for this company: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K This story originally appeared on Fintel. |
End of preview.
FNSPID: A Comprehensive Financial News Dataset in Time Series
FOR THE ORIGINAL DATASET, SEE: Zihan1004/FNSPID.
This is a reduced version of the dataset, to make it easier to load in different context.
- Downloads last month
- 17